Global Alzheimers Disease Market Research Report 2019 (Includes Business Impact of COVID-19)
- TBI425001
- March 18, 2019
- Global
- 93 pages
- QY Market Research
"The ongoing Coronavirus (COVID-19) pandemic is re-shaping everything from global economies to product categories, pricing, and stock availability to the consumer behavior. The final report is updated to address the impact of COVID-19 on the Alzheimers Disease market.
Trusted Business Insights is tracking mining/oil and gas, transportation, employment services, travel arrangements, and the leisure and hospitality sector closely as they are likely to be the hardest-hit sectors. Utilities, local pharma, diagnostics, consumer goods and durables, agro chem and fertilizers, and telecommunications are the sectors that will be weathering the COVID-19 storm and most likely come out relatively unscathed. Interdependencies of sectors are factored in our research report on the Alzheimers Disease market."
Alzheimers disease is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60“70% of cases of dementia. The most common early symptom is difficulty in remembering recent events (short-term memory loss).
The global Alzheimers Disease market is valued at 2900 million US$ in 2018 is expected to reach 10500 million US$ by the end of 2025, growing at a CAGR of 17.5% during 2019-2025.
This report focuses on Alzheimers Disease volume and value at global level, regional level and company level. From a global perspective, this report represents overall Alzheimers Disease market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Allergan
Eisai
Novartis
Daiichi Sankyo
Merz Pharma
Pfizer
Johnson & Johnson
Lundbeck
Segment by Regions
North America
Europe
China
Japan
Segment by Type
Donepezil
Memantine
Rivastigmine
Segment by Application
Early to Moderate Stages
Moderate to Severe Stages
Table of Contents
Executive Summary
1 Alzheimer's Disease Market Overview
1.1 Product Overview and Scope of Alzheimer's Disease
1.2 Alzheimer's Disease Segment by Type
1.2.1 Global Alzheimer's Disease Production Growth Rate Comparison by Type (2014-2025)
1.2.2 Donepezil
1.2.3 Memantine
1.2.4 Rivastigmine
1.3 Alzheimer's Disease Segment by Application
1.3.1 Alzheimer's Disease Consumption Comparison by Application (2014-2025)
1.3.2 Early to Moderate Stages
1.3.3 Moderate to Severe Stages
1.4 Global Alzheimer's Disease Market by Region
1.4.1 Global Alzheimer's Disease Market Size Region
1.4.2 North America Status and Prospect (2014-2025)
1.4.3 Europe Status and Prospect (2014-2025)
1.4.4 China Status and Prospect (2014-2025)
1.4.5 Japan Status and Prospect (2014-2025)
1.5 Global Alzheimer's Disease Market Size
1.5.1 Global Alzheimer's Disease Revenue (2014-2025)
1.5.2 Global Alzheimer's Disease Production (2014-2025)
2 Global Alzheimer's Disease Market Competition by Manufacturers
2.1 Global Alzheimer's Disease Production Market Share by Manufacturers (2014-2019)
2.2 Global Alzheimer's Disease Revenue Share by Manufacturers (2014-2019)
2.3 Global Alzheimer's Disease Average Price by Manufacturers (2014-2019)
2.4 Manufacturers Alzheimer's Disease Production Sites, Area Served, Product Types
2.5 Alzheimer's Disease Market Competitive Situation and Trends
2.5.1 Alzheimer's Disease Market Concentration Rate
2.5.2 Alzheimer's Disease Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Alzheimer's Disease Production Market Share by Regions
3.1 Global Alzheimer's Disease Production Market Share by Regions
3.2 Global Alzheimer's Disease Revenue Market Share by Regions (2014-2019)
3.3 Global Alzheimer's Disease Production, Revenue, Price and Gross Margin (2014-2019)
3.4 North America Alzheimer's Disease Production
3.4.1 North America Alzheimer's Disease Production Growth Rate (2014-2019)
3.4.2 North America Alzheimer's Disease Production, Revenue, Price and Gross Margin (2014-2019)
3.5 Europe Alzheimer's Disease Production
...
| read more...
Related Reports
